139 related articles for article (PubMed ID: 3303928)
61. Hypophosphatemic osteomalacia complicating von Recklinghausen's neurofibromatosis: increase in spinal density on treatment.
Hogan DB; Anderson C; MacKenzie RA; Crilly RG
Bone; 1986; 7(1):9-12. PubMed ID: 3083847
[TBL] [Abstract][Full Text] [Related]
62. Secondary hyperparathyroidism in osteomalacia.
Thalassinos NC; Wicht S; Joplin GF
Br Med J; 1970 Jan; 1(5688):76-9. PubMed ID: 5411449
[TBL] [Abstract][Full Text] [Related]
63. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
[TBL] [Abstract][Full Text] [Related]
64. Ethmoid tumor and oncogenic osteomalacia: Case report and review of the literature.
Villepelet A; Casiraghi O; Temam S; Moya-Plana A
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Oct; 135(5):365-369. PubMed ID: 30026073
[TBL] [Abstract][Full Text] [Related]
65. Deliberate total parathyroidectomy: a potentially novel therapy for tumor-induced hypophosphatemic osteomalacia.
Bhadada SK; Palnitkar S; Qiu S; Parikh N; Talpos GB; Rao SD
J Clin Endocrinol Metab; 2013 Nov; 98(11):4273-8. PubMed ID: 23956343
[TBL] [Abstract][Full Text] [Related]
66. Calcium and phosphorus metabolism in chronic uremia.
Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E
Nephron; 1975; 14(2):163-80. PubMed ID: 1093055
[TBL] [Abstract][Full Text] [Related]
67. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.
Apostolou T; Damianou L; Kotsiev V; Drakopoulos S; Hadjiconstantinou V
Clin Nephrol; 2006 May; 65(5):374-7. PubMed ID: 16724661
[TBL] [Abstract][Full Text] [Related]
68. [Tumor-induced osteomalacia in a patient with a phosphaturic mesenchymal tumor revealing feature of an ossifying fasciitis of the left abdominal wall].
Oba K; Takei A; Natori S; Arai K; Nakanishi K; Oda Y
Nihon Naika Gakkai Zasshi; 2002 Jun; 91(6):1870-2. PubMed ID: 12170756
[No Abstract] [Full Text] [Related]
69. [A case of adult onset hypophosphatemic vitamin D resistant osteomalacia].
Katagiri T; Suzuki T; Akiyama Y; Ishibashi T; Hara K; Oka H; Imai T; Kobayashi K; Kitagawa H; Ohno S
Ryumachi; 1992 Oct; 32(5):461-7; discussion 466-7. PubMed ID: 1440082
[TBL] [Abstract][Full Text] [Related]
70. Medical treatment in primary and secondary hyperparathyroidism.
Coburn JW; Brickman AS; Massry SG
Semin Drug Treat; 1972; 2(1):117-35. PubMed ID: 4261783
[No Abstract] [Full Text] [Related]
71. Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23.
Ogura E; Kageyama K; Fukumoto S; Yagihashi N; Fukuda Y; Kikuchi T; Masuda M; Suda T
Intern Med; 2008; 47(7):637-41. PubMed ID: 18379151
[TBL] [Abstract][Full Text] [Related]
72. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma.
Fuentealba C; Pinto D; Ballesteros F; Pacheco D; Boettiger O; Soto N; Fernandez W; Gabler F; Gonzales G; Reginato AJ
J Clin Rheumatol; 2003 Dec; 9(6):373-9. PubMed ID: 17043447
[TBL] [Abstract][Full Text] [Related]
73. [Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].
Chazal T; Khanine V; Lidove O; Godot S; Ziza JM
Rev Med Interne; 2017 Jun; 38(6):412-415. PubMed ID: 27659744
[TBL] [Abstract][Full Text] [Related]
74. Treatment of vitamin D deficient osteomalacia may unmask autonomous hyperparathyroidism.
Taylor AV; Wise PH
Postgrad Med J; 1997 Dec; 73(866):813-5. PubMed ID: 9497953
[TBL] [Abstract][Full Text] [Related]
75. [Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation].
Vaquero E; Esteban de la Rosa RJ; Oliva N; Fernández Castillo R; Fernández Gallegos R; Bravo Soto J
Med Clin (Barc); 2012 Apr; 138(8):323-6. PubMed ID: 21492884
[TBL] [Abstract][Full Text] [Related]
76. Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia.
Nguyen BD; Wang EA
Clin Nucl Med; 1999 Feb; 24(2):130-1. PubMed ID: 9988077
[No Abstract] [Full Text] [Related]
77. [Hypophosphatemic osteomalacia in adults].
Löhr-Schwaab S; Wanner C; Reinbold WD; Schümichen C; Schölmerich J; Schaefer HE; Gerok W
Dtsch Med Wochenschr; 1989 Apr; 114(14):538-42. PubMed ID: 2702931
[TBL] [Abstract][Full Text] [Related]
78. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine.
Pirola E; Vergani F; Casiraghi P; Leone EB; Guerra P; Sganzerla EP
J Neurosurg Spine; 2009 Apr; 10(4):329-33. PubMed ID: 19441990
[TBL] [Abstract][Full Text] [Related]
79. Oncogenic osteomalacia: strange tumours in strange places.
Weiss D; Bar RS; Weidner N; Wener M; Lee F
Postgrad Med J; 1985 Apr; 61(714):349-55. PubMed ID: 4022870
[TBL] [Abstract][Full Text] [Related]
80. Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity.
Mosekilde L; Melsen F; Hessov I; Christensen MS; Lund BJ; Lund BI; Sørensen OH
Gut; 1980 Jul; 21(7):624-31. PubMed ID: 7429327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
